Key facts
- This page summarizes Scott C. Syphax's Form 4 filing for PROASSURANCE CORP (PRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Jun 2026, 12:22.
Scott C. Syphax - 26 Jun 2026 Form 4 Insider Report for PROASSURANCE CORP (PRA)
- Reporting relationship
- Director
- Issuer ticker
- PRA
- Reported as of
- 26 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Jun 2026, 12:22:42 UTC
- Prior SEC filing
- 21 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Lee M. Pope, with Power of Attorney for the Reporting Person
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Scott C. Syphax filed Form 4 for PROASSURANCE CORP (PRA) on 26 Jun 2026.
Change
- Previous filing in this sequence was filed on 21 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001862744
Primary reporting owner
SYPHAX SCOTT C
- Relationship
- Director
- Address
- 100 BROOKWOOD PLACE, BIRMINGHAM
- Signature
- Lee M. Pope, with Power of Attorney for the Reporting Person
- Signature date
- 26 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PRA
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -25,184
- Change %
- -100%
- Price
- $25.00*
- Shares after
- 0
- Date
- 26 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Scott C. Syphax is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
On June 26, 2026, pursuant to that certain Agreement and Plan of Merger, dated as of March 19, 2025 (the "Merger Agreement"), among ProAssurance Corporation (the "Issuer"), The Doctors Company ("Parent") and Jackson Acquisition Corporation, a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent.
Footnote F2
Represents shares awarded under the ProAssurance Corporation Director Deferred Stock Compensation Plan ("Deferred Shares"). At the effective time of the Merger ("Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, the Deferred Shares, and any accrued dividend equivalents in such deferred compensation accounts that have been converted into Deferred Shares were converted into the right to receive an amount in cash, without interest, equal to the product of (a) the total number of shares of the Issuer's common stock, par value $0.01 per share (the "Common Stock") subject to the Deferred Shares immediately prior to the Effective Time, multiplied by (b) the Merger Consideration (as defined below).
Footnote F3
At the Effective Time, upon the terms and subject to the conditions set forth in the Merger Agreement, each share of Common Stock that was issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive $25.00 per share in cash, without interest, and subject to any applicable withholding taxes (the "Merger Consideration").